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Abstract
As part of a screening programme for antibiotic-producing bacteria, a novel Actinomadura
species was discovered from a soil sample collected in Santorini, Greece. Preliminary 16S
rRNA gene sequence comparisons highlighted Actinomadura macra as the most similar
characterised species. However, whole-genome sequencing revealed an average nucleo-
tide identity (ANI) value of 89% with A. macra, the highest among related species. Further
phenotypic and chemotaxonomic analyses confirmed that the isolate represents a previ-
ously uncharacterised species in the genus Actinomadura, for which the name Actinoma-
dura graeca sp. nov. is proposed (type strain 32-07T). The G+C content of A. graeca 32–07
is 72.36%. The cell wall contains DL-diaminopimelic acid, intracellular sugars are glucose,
ribose and galactose, the predominant menaquinone is MK-9(H6), the major cellular lipid is
phosphatidylinositol and fatty acids consist mainly of hexadecanoic acid. No mycolic acid
was detected. Furthermore, A. graeca 32–07 has been confirmed as a novel producer of the
non-ribosomal peptide antibiotic zelkovamycin and we report herein a provisional descrip-
tion of the unique biosynthetic gene cluster.
Introduction
As originally described [1] and successively revised [2–6], the genus Actinomadura defines a
variety of aerobic, Gram-positive, non-motile, non-acid-alcohol-fast, chemoorganotrophic soil
actinomycetes. These microbes form extensively branched, non-fragmenting substrate myce-
lium, most often accompanied by aerial hyphae that can maturate into straight, curled, hooked
or spiralled spore chains carrying up to 50 arthrospores with a smooth, irregular, rugose,
folded, warty or spiny surface. Single spherical spore vesicles may also be produced. Although
Actinomadura strains are mostly mesophilic and non-pathogenic, some thermophiles have
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also been identified and strains that are pathogenic to both men and domestic/farm animals
[7] are known.
From a chemotaxonomic point of view, Actinomadurae are characterised by a type III cell
wall, containing both meso-2,6-diaminopimelic acid (meso-DAP) and N-acetylated muramic
acid [8], as well as type A1γ peptidoglycan [9]. The plasma membrane contains the non-
nitrogenous phospholipids phosphatidylinositol (PI), diphosphatidylglycerol (DPG), phospha-
tidylglycerol (PG) and a fraction of phosphatidylinositol mannosides (PIMs), in accordance
with a type PI lipid composition [10]. Fatty acid tails mainly consist of hexadecanoic acid
(C16:0), 14-methylpentadecanoic acid (iso-C16:0) and 10-methyloctadecanoic acid (10-meth-
C18:0), generally classified as type 3a [11]. Galactose, glucose, mannose, ribose and madurose
(3-O-methyl-D-galactose) are most abundant within the cell, consistent with a type B sugar
composition [8]. Respiratory isoprenoid quinones are predominantly MK-9(H6) menaqui-
nones saturated at sites II, III and VIII, with small amounts of MK-9(H4) (saturated at sites II
and III) and MK-9(H8), in line with type 4B2 quinone profile [11]. Mycolic acids are not
found in the genus. The G+C composition ranges between 65–73 mol% [7].
As part of a screening programme for antibiotic-producing bacteria, a new microorganism
has been isolated from a soil sample collected in Santorini, Greece. The new strain (designated
32–07) was attributed to the genus Actinomadura via 16S rRNA analysis and later dereplicated
as a novel producer of zelkovamycin, a macrocyclic peptide antibiotic previously found only in
Streptomyces species [12–15]. The full chemical structure of zelkovamycin was recently estab-
lished [15]. As part of this work, the chromosomal and plasmid DNA of Actinomadura sp. 32–
07 has been fully sequenced and the strain subjected to phenotypic, chemotaxonomic and
genomic analyses. Furthermore, a bioinformatic approach has been used to identify the genetic
cluster coding for the non-ribosomal peptide synthetase system responsible for the biosynthe-
sis of zelkovamycin. Although the list of zelkovamycin-susceptible microorganisms identified
to date is fairly limited, the potential strength of this antibiotic lies on its apparent high speci-
ficity towards Staphylococcus aureus [12, 13]. Particularly interesting would be the potential
clinical use of zelkovamycin to treat multi-drug resistant staphylococcal infections.
Materials and methods
Strain isolation, maintenance and cultural conditions
Strain 32–07 was isolated from a soil sample collected in Santorini (Greece) (S1 File).
Biomass from mature cultures (typically 14–21 days old) was used to preserve the strain.
Agar plates were kept at 4 ˚C for short-term storage, while liquid cultures in 30% (v/v) glycerol
were frozen at -80 ˚C for long-term storage. Fresh mycelium or glycerol stocks of mycelium
and/or spores were routinely grown on ISP medium 1 or 2 and GYEA medium [16, 17].
Morphological, cultural and physiological properties
Unless stated otherwise, cultures used for morphological, cultural and physiological tests were
grown at 28 ˚C and observations made after 7, 14 and 21 days of growth. Biological media
used included: ISP medium 1–7 and 9 [16], glucose-yeast extract agar (GYEA: 15 g/L bacterio-
logical agar, 10 g/L glucose, 10 g/L yeast extract, pH 6.8) [17], yeast extract-iron agar (YEIA:
7.5 g/L bacteriological agar, 3.0 g/L yeast extract, 0.5 g/L ammonium ferric citrate) [18], nutri-
ent agar (NA: 15 g/L bacteriological agar, 5.0 g/L peptone, 3.0 g/L beef extract, pH 7.0) [19],
milk agar (50 g/L skim milk powder, 10 g/L bacteriological agar) [20], peptone-salts agar (PSA:
15 g/L bacteriological agar, 10 g/L peptone, 5.0 g/L NaCl, 0.1 g/L CaCI2•H2O, pH 7.4) [21],
urease broth (18 g/L urea, 9.5 g/L Na2HPO4, 9.1 g/L KH2PO4, 0.1 g/L yeast extract, 0.01 g/L
phenol red, pH 6.8) [22], nitrate broth (5.0 g/L peptone, 3.0 g/L beef extract, 1.0 g/L KNO3, pH
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7.0) [19] and Tsukamura’s medium (3% glycerol, 20 g/L bacteriological agar, 1.123 g/L triso-
dium citrate•2H2O, 0.5 g/L KH2PO4, 0.5 g/L MgSO4•7H2O, pH 7.0) [23].
Morphological observations were made on mature mycelial (14–21 days old) grown on ISP
medium 2 or GYEA. For light microscopy, heat-fixed suspensions of mycelia on a glass slide
were stained with 0.5% malachite green under constant heating (~90 ˚C for 5 min), thoroughly
washed and briefly counterstained with 0.25% safranin O (30 s). After removing the excess
stain, samples were dried and visualised using an Eclipse 50i fluorescence microscope (Nikon)
with a Digital Sight DS-Fi1 microscope camera controller (Nikon) and NIS-Elements micro-
scope imaging software (Nikon). For scanning electron microscopy, mycelia were fixed in 3%
glutaraldehyde/0.1 M Na-cacodylate buffer (pH 7.2) and post-fixed with 1% OsO4. Following
dehydration with an EtOH series, samples were dried with hexamethyldisilazane (HMDS) and
coated with a 5 nm iridium layer. All samples were imaged using a JEOL 7100F FEG-SEM.
Environmental SEM on fixed, uncoated samples was performed using a Quanta650 ESEM
(FEI) with a tungsten filament and a GSED or LFD detector.
The pigmentation of the aerial and substrate mycelium of mature cultures was recorded
after growth in selected media. Production of melanoid pigments was assessed on ISP medium
1, 6 and 7 after 2, 4 and 21 days of growth.
The ability of the strain to grow at different temperatures (4, 10, 22, 28, 37 and 45 ˚C), pH
(4.0–11.0 in 1.0 increments) and salinity (0–7% in 1% increments) was tested in 96-well plates
using GYEA as the basal growth medium.
Growth on sole carbon sources was assessed after 21 days of growth on ISP medium 9 sup-
plemented with 1% (w/v) of myo-inositol, D-mannitol, L-arabinose, D-fructose, D-glucose, L-
rhamnose, D-xylose, sucrose, raffinose or cellulose.
Growth on sole nitrogen sources was assessed on Tsukamura’s medium supplemented with
0.1% (w/v) of ammonium sulphate, L-arginine, L-glutamine, glycine, L-histidine, L-leucine, L-
methionine, L-phenylalanine or L-valine.
Degradation of aesculin and arbutin (both at 0.1% w/v) was tested in 90 mm Petri dishes
using YEIA as the basal growth medium. The development of rich brown pigment (or a deeper
colouration than the negative control) around and/or underneath the growth in the test media
was recorded as a positive result.
Degradation of elastin (0.3% w/v), hypoxanthine (0.4% w/v), testosterone (0.1% w/v), xan-
thine (0.4% w/v) and xylan (0.4% w/v) was tested in 90 mm Petri dishes using GYEA as the
basal growth medium. The disappearance of the insoluble crystals around and/or underneath
the growth in the test media was recorded as a positive result.
Degradation of gelatine (0.4% w/v), starch (1% w/v), tributyrin (1% w/v) and (L)-tyrosine
(0.5% w/v) was tested in 90 mm Petri dishes using NA as the basal growth medium. The for-
mation of a clear zone around and/or underneath the growth in the tributyrin medium was
recorded as a positive result. The appearance of a clear zone around the growth after flooding
the plates with an aqueous solution of 1% tannic acid (for the gelatine medium) or with 95%
ethanol (for the starch medium) was recorded as a positive result [19, 24].
Degradation of casein was tested in 90 mm Petri dishes using milk agar as the growth
medium. Clearing of the opaque medium around and/or underneath the growth in the test
medium was recorded as a positive result.
Degradation of Tween 20, 40, 60 and 80 (all at 1% v/v) was tested in 90 mm Petri dishes
using PSA as the basal growth medium. The formation of an opaque halo around and/or
underneath the growth in the test media was recorded as a positive result.
Oxidase activity was tested in 90 mm Petri dishes using NA as the growth medium. The
mycelial growth was harvested, and the presence of enzymatic activity detected with
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commercially available oxidase test strips (Honeywell Fluka). The production of a dark purple
colour was recorded as a positive result.
Catalase activity was tested in 24-well plates using NA as the growth medium. The evolution
of gas from the mycelial growth after flooding the inoculated wells with 3–6% H2O2 was
recorded as a positive result [25].
Urease activity was tested in 5 mL test tubes using urease broth as the growth medium. The
production of red colour in the test medium was recorded as a positive result [22].
H2S production was tested in 15 mL slant tubes using ISP medium 6 as the growth medium.
A commercial H2S test strip (Sigma) was inserted between the cap and the tube throughout
the incubation period. Blackening of the strip or the test medium was recorded as a positive
result [25].
Nitrate reduction was tested in 50 mL tubes using nitrate broth as the growth medium. The
content of nitrate (NO3
-) and nitrite (NO2
-) was measured using a commercial nitrate/nitrite
test stick (Quantofix) and an increase of the nitrite concentration in the test medium was
recorded as a positive result.
Antibiotic susceptibility testing was performed by the DSMZ Identification Service (Braun-
schweig, Germany) according to the standard DIN disc diffusion method [26], using 5, 10, 15,
20, 30, 40, 50, 75, 100 or 300 μg of antibiotic per disc.
Chemotaxonomic characteristics
The analysis of chemotaxonomic features was carried out by the DSMZ Identification Service
(Braunschweig, Germany) according to the procedures outlined below.
Cellular fatty acids were saponified, methylated and extracted from an actively growing cul-
ture using minor modifications of the methods of Miller and Kuykendall [27, 28] and a Sher-
lock Microbial Identification System (MIS) (MIDI Inc., Newark, USA) consisting of an
Agilent 6890N gas chromatograph fitted with a 5% phenylmethyl silicone capillary column
(0.2 mm x 25 m), a flame ionization detector and an Agilent 7683A automatic sampler. Data
were analysed with MIS Standard Software against a proprietary database [29], (MIDI Inc.,
Newark, USA).
Respiratory quinones and lipoquinones were extracted from freeze-dried cells using the
two-stage method described by Tindall [30, 31]. Menaquinones were separated by TLC on sil-
ica gel and further analysed by RP-HPLC on an LDC Analytical system (Thermo Separation
Products) fitted with a reverse-phase C18 column (Macherey-Nagel, 2 mm x 125 mm, 3 μm,
RP-18) and the effluent monitored at 269 nm.
Polar lipids were extracted from freeze-dried biomass (after lipoquinones extraction) using
a modification of the method of Bligh and Dyer [32] and separated by two-dimensional TLC
on silica gel. Total lipid material was detected as described by Tindall [33].
The presence of 2,6-diaminopimelic acid (DAP) isomers or OH-DAP in whole-cell hydro-
lysates was determined by TLC on cellulose plates using the solvent system of Rhuland [34].
Whole-cell sugars from cell hydrolysates were analysed by TLC on cellulose plates accord-
ing to Staneck and Roberts [35].
Mycolic acids were extracted and analysed as described elsewhere [36].
Genomic and phylogenetic analyses
The genomic DNA of Actinomadura sp. 32–07 was extracted using Zymo Research Soil
Microbe DNA Kit (Zymo Research, USA). Subsequently, the purity and quantity of the
extracted genomic DNA were measured using NanoDrop 2000 spectrophotometer (Thermo
Fisher Scientific, Waltham, MA, USA) and Qubit 2.0 fluorometer (Thermo Fisher Scientific,
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Waltham, MA, USA), respectively [37]. A 20-kb template library was prepared using the Blue-
Pippin size-selection system and the full genome is sequenced using a Pacific Biosciences RS II
platform with P5-C3 chemistry following the MagBead loading protocol (Pacific Biosciences,
Menlo Park, CA) [38]. The average sequencing coverage is 122.82 times. De novo assembly of
the genome was performed using Hierarchical Genome Assembly Process (HGAP) version 2.0
[39]. The circularity of the assembled genome was investigated using Contiguity [40] and the
overlapping ends were trimmed using Minimus2 of the AMOS software package [41]. The
sequenced genome was annotated using Prokka 1.11 [42].
Genome-based identification of strain 32–07 was performed with EZBioCloud’s TrueBac™
service [43] using the complete sequence of Actinomadura sp. 32–07. The average nucleotide
identity (ANI) and the similarity values of selected genes for the 15 most similar species pres-
ent in the database were returned as part of the results.
For the phylogenetic analysis, the 16S rRNA gene consensus of strain 32–07 was compared
with the homologous sequence from type strains of Actinomadura species with validly pub-
lished names as of July 2019 [44, 45] obtained from the SILVA database [46]. The sequences
were aligned using MUSCLE [47, 48] and the alignment was manually verified and adjusted
prior to the construction of phylogenetic trees in MEGA X [49] using the neighbour-joining
(NJ), maximum likelihood (ML) and maximum parsimony (MP) methods [50–52]. For the NJ
method, the evolutionary distances were computed using the p-distance method. For the ML
analysis, the Tamura-Nei model [53] was used in conjunction with discrete Gamma distribu-
tion (+G, 5 categories, parameter = 0.3769) and assuming evolutionarily invariable sites (+I,
39.89% of sites). Initial tree(s) for the heuristic search were obtained automatically by applying
Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using the
Maximum Composite Likelihood (MCL) approach, and then selecting the topology with
superior log likelihood value. The MP tree was obtained using the Tree-Bisection-Regrafting
(TBR) algorithm with search level 3, in which the initial trees were obtained by the random
addition of sequences (10 replicates). For all trees, positions with less than 80% site coverage
were eliminated before the analysis (partial deletion option) and the stability of the clades was
appraised by bootstrap analysis with 1000 replicates [54]. When available, Actinomadura
sequences of the RNA polymerase subunit genes rpoB/rpoC were collected and analysed in the
same way.
Prediction of secondary metabolite biosynthetic clusters was performed on the complete
genome using antiSMASH 5.0 [55]. The results were manually inspected and a candidate clus-
ter matching the putative arrangement of zelkovamycin synthetase (inferred from the chemical
structure of zelkovamycin) was selected.
Fermentation, extraction and detection of zelkovamycin
For the fermentative production of zelkovamycin, mature growth from a single GYEA plate
was used to start an inoculum culture in 100 mL of seed broth (18 g/L dextrose, 8 g/L soytone,
4 g/L CaCO3, 2 g/L yeast extract, 1 g/L NaCl, pH 7.3) and incubated with shaking (200 RPM)
for 5 days at 30 ˚C. Biomass from the seed broth was harvested, triturated and used to inocu-
late 100 mL of the fermentation broth (20 g/L soluble starch, 8 g/L casamino acids, 3 g/L
CaCO3, 2 g/L proteose peptone No. 3, 2 g/L yeast extract, 1 g/L dextrose). Fermentation was
carried out with shaking (200 RPM) for 10 days at 30 ˚C.
Biomass was harvested from the fermentation broth by centrifugation and zelkovamycin
was extracted from the cleared medium using Diaion HP-20 polystyrene resin (Sigma-
Aldrich) at a ratio of 1 g per 40 mL. After 2 h of incubation at room temperature with gentle
shaking (200 RPM), the resin was recovered and loaded into a 10-mL disposable PD-10
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chromatography column (GE Healthcare) and stepwise elution performed with increasing
concentrations of methanol.
The eluates were analysed by LC-MS on an Accela modular system (ThermoScientific,
Hemel Hempstead, UK) equipped with a Gemini C18 2μ (100 x 3 mm) chromatography col-
umn (Phenomenex). Stepwise elution was performed with increasing concentrations of aceto-
nitrile in 0.1% aqueous formic acid. Mass spectra were collected using an Exactive orbital ion-
trap mass spectrometer (ThermoScientific, Hemel Hempstead, UK) over a run time of 15 min
with an m/z acquisition range of 150–1000. Commercially available zelkovamycin (AdipoGen)
was used as a standard for the optimisation of the detection method, and the characteristic
ion-mass signal of zelkovamycin was used in all subsequent analyses.
Antimicrobial susceptibility testing
The in vitro antimicrobial activity of commercial zelkovamycin (AdipoGen) and zelkovamycin
extracts from fermentation broth was determined by applying test samples to antimicrobial
susceptibility test discs (Oxoid) and using Staphylococcus aureus SH1000, according to the
EUCAST disk diffusion method [56].
Results and discussion
As part of a screening campaign to identify novel producers of antibacterial compounds, the
broth extract of the microorganism ‘(ID) 32–07’ was initially found to display potent anti-S.
aureus activity. Following routine HPLC separation, and MS ([M+H]+ = 780.846, [M+NH4]+
= 797.89; [M+Na]+ = 802.90) and UV spectrum (a major peak at 227 nm and a shoulder at 291
nm) analyses of a single fraction, the anti-S. aureus activity was ascribed to the macrocyclic
peptide, zelkovamycin. Preliminary 16S rRNA analysis of the producer strain suggested it is a
previously uncharacterised Actinomadura species.
In order to elucidate the taxonomic position of isolate 32–07, a genomic and phylogenetic
evaluation was initially performed on its complete genome sequence. A polyphasic approach
consisting of morphological, cultural, physiological and chemotaxonomic analyses was then
applied to compare the strain to its phylogenetically closest relative.
Genomic and phylogenetic analyses
The annotated sequences for the whole chromosomal and plasmid DNA have been deposited
in the GenBank database under accession numbers CP059572 (chromosome), CP059573
(plasmid 1) and CP059574 (plasmid 2).
The in silico genome analysis of isolate 32–07 identified it as an Actinomadura species.
Based on average nucleotide identity (ANI) over whole genomes, the most similar species pres-
ent in the database was Actinomadura macra NBRC 14102T [57] (89.61%), followed by Actino-
madura fibrosa (86.70%), Actinomadura roseirufra (86.66%), Actinomadura formosensis
(86.23%), Actinomadura nitritigenes (86.22%) and Actinomadura geliboluensis (86.18%)
(Table 1). All values were well below the accepted 95–96% threshold for species circumscrip-
tion [58], suggesting that the novel isolate constitute a phylogenetically-separate species.
The phylogenetic position of Actinomadura sp. 32–07 was further investigated by obtaining
a multiple alignment between its 16S rRNA gene sequence and that of other species in the
genus Actinomadura, from which NJ, ML and MP trees were reconstructed. In all three cases,
the strain formed a clade with A. macra NBRC 14102T, supporting the existence of a close evo-
lutionary relationship between the two, albeit the low number of occurrences among all itera-
tions of each tree reflected their somewhat loose similarity (Fig 1). An equivalent analysis with
the rpoB/rpoC sequences, when these are available, produced the same result (S1 Fig).
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Morphological, cultural and physiological properties
After 5–7 days of incubation on ISP medium 2, strain 32–07 formed small, flat, spherical colo-
nies that subsequently rapidly increased in size, reaching up to 1 mm in height and 2 mm in
width after 21 days of growth. Mature colonies developed a multi-lobate toroidal shape charac-
terised by four major lobes splitting in two minor sectors around a central hollow pit (Fig 2A).
Under microscopic observation, colonies revealed an extensively branching substrate myce-
lium carrying aerial hyphae with an average diameter of 0.5 μm, which often differentiated
into long, flexuous spore chains appearing as a series of subtle oval swellings stemming from
an otherwise similar filament. Single round terminal swellings were sometimes also observed.
As the presence of spores in spore chains was not always obvious by scanning electron micros-
copy (SEM), a combination of light microscopy and endospore staining was employed. This
method allowed the detection of an average of 10–20 spores per chain (Fig 2B and 2C). Once
released from the hyphae, spores appeared spherical and smooth under SEM and measured
0.2–0.3 μm in diameter (Fig 2D).
Growth on agar media was generally good on GYEA, NA and ISP medium 2, moderate on
ISP 3 and poor on IPS 4, 5, 6, 7 and Tsukamura’s medium. The coloration of the aerial myce-
lium varied from white to grey on ISP medium 2, pink to white and grey on ISP 3, yellow to
white on ISP 4, dark green to dark brown on ISP 5, pink to white on ISP 6, brown on ISP 7
and ISP 9 supplemented with glucose or sucrose, yellow to brown on GYEA, white with pink-
ish on NA and dark green to dark brown on Tsukamura’s medium. The substrate mycelium
was dark brown on ISP medium 2, pink on ISP 3, white on ISP 4, yellow-brown with green on
ISP 5, pink on ISP 6, brown on ISP 7, yellow-brown with orange on GYEA or ISP 9 supple-
mented with glucose, yellow-brown on ISP 9 supplemented with sucrose, orange with pink on
NA and dark grey on Tsukamura’s medium.
When treated with aqueous acid (0.05 M HCl), the substrate mycelium of cultures grown
on ISP medium 2, 3 and 9 (both with glucose and sucrose) lost its colouration to different
extent. Under basic conditions (0.05 M NaOH), mild to intense discolouration was also
observed on ISP 3, 5 and 9 (both with glucose and sucrose). Diffusible melanoid pigments
were not produced on ISP medium 6 and 7 or in any other tested media, but soluble colours
other than brown or black could be observed on ISP 1 (light yellow), GYEA (orange, disco-
louring at basic pH) and Tsukamura’s medium (dark yellow).
The physiological properties of Actinomadura sp. 32–07 included the utilisation of D-glu-
cose and sucrose as sole carbon sources on ISP medium 9, but not myo-inositol, D-mannitol,
L-rhamnose, raffinose or cellulose (utilisation of L-arabinose, D-fructose and D-xylose was
uncertain). On Tsukamura’s medium, none of the tested nitrogen sources (ammonium sul-
phate, arginine, glutamine, glycine, histidine, leucine, methionine, phenylalanine and valine)
Table 1. Whole-genome comparison between Actinomadura sp. 32–07 and closely related Actinomadura species identified by TrueBac™.
A. macra A. fibrosa A. roseirufra A. formosensis A. nitritigenes A. geliboluensis
NBRC 14102T
ANI 89.61% 86.70% 86.66% 86.23% 86.22% 86.18%
ANI coverage 70.7% 37.70% 41.0% 35.20% 32.27% 32.0%
16S similarity 99.03% 98.25% 98.61% 98.33% 98.03% 98.54%
recA similarity 91.69% N/A 93.28% 94.20% N/A 74.14%
rplC similarity 100% 100% N/A 96.47% 96.47% 96.47%
All ANI values fall below the designated threshold for species circumscription (95–96%). N/A = not available.
https://doi.org/10.1371/journal.pone.0260413.t001
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Fig 1. Maximum likelihood tree generated from nearly complete 16S rRNA gene sequences showing the
relationship between Actinomadura sp. 32–07 and the type strains of species with validly published names in the
genus Actinomadura. Thermomonospora curvata DSM 43183T was used as an outgroup. The tree with the highest log
likelihood is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap
test (1000 replicates) is shown next to the branches (only values above 40% are shown). The tree is drawn to scale, with
branch lengths measured in number of substitutions per site (bar = 0.01 substitutions per site). Nodes marked with a
full circle were also recovered in the neighbour-joining and maximum parsimony trees. T’s at the end of strain names
indicate type strains.
https://doi.org/10.1371/journal.pone.0260413.g001
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was found to produce abundant growth by itself, although darkening of the pre-existing myce-
lial inoculum became evident in most cases (particularly with phenylalanine and valine) and
colouration of the medium was observed in all inoculated media (including the negative con-
trol, lacking any nitrogen source). On GYEA, strain 32–07 was able to grow between 28 and 37
˚C, showed a pH optimum of 6.0–8.0 and could tolerate up to 3% (w/v) of NaCl. The metabolic
and enzymatic capabilities of the isolate were assessed. Positive tests included degradation of
aesculin, arbutin, hypoxanthine, gelatine, starch, L-tyrosine, casein, Tween 20, Tween 40,
Tween 60 and Tween 80, as well as catalase activity, H2S production and nitrate reduction. On
the other hand, the strain was negative for the degradation of elastin, xanthine, xylan and tri-
butyrin, as well as for oxidase and urease activity.
The most effective antibiotics (diameter of inhibition�50 mm) were bacitracin, imipenem,
linezolid, ticarcillin and clindamycin, but appreciable sensitivity (diameter of inhibition 40–44
mm) to ampicillin, piperacillin, ceftriaxone, moxifloxacin, and chloramphenicol was also
Fig 2. Photographic, light microscopy and electron microscopy images of Actinomadura sp. 32–07. After 21 days of growth on ISP medium 2,
colonies are characterised by four major lobes, which often split in two minor sectors, and a central hollow pit (A, no magnification). Spore chains
appear as long, flexuous series of subtle oval swelling stemming from a thinner, smooth hypha. Endospores inside the swellings can be viewed by light
microscopy after staining with malachite green and counterstaining with safranin O (B, 100X magnification) or by closer inspection with electron
microscopy (C, 8,500X magnification). Free spores of Actinomadura sp. 32–07 appear spherical and smooth, measuring 200–300 nm in diameter (D,
20,000X magnification).
https://doi.org/10.1371/journal.pone.0260413.g002
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detected. Neomycin was shown to have lesser effect (diameter of inhibition < 36 mm). Actino-
madura sp. 32–07 was found to be resistant to aztreonam, norfloxacin, nitrofurantoin and
fosfomycin.
A list of the morphological, cultural and physiological properties that differentiate Actino-
madura sp. 32–07 from A. macra NBRC 14102T is presented in Table 2.
Chemotaxonomic characteristics
The chemotaxonomic markers of Actinomadura sp. 32–07 were in line with those of other
members of the genus Actinomadura (Table 3). The DL-2,6-diaminopimelic acid (DL-DAP)
was detected as the cross-linking amino acid of peptidoglycan, while no mycolic acids were
found. Phosphatidylinositol (PI), diphosphatidylglycerol (DPG) and phosphoglycolipids
(PGL) were the predominant phospholipids in the plasma membrane and mostly contained
fatty acids, such as hexadecanoic acid (palmitic acid, C16:0), cis-9-octadecenoic acid (oleic
acid, C18:1 ω9c), 10-methyloctadecanoic acid (tuberculostearic acid, 10-methyl-C18:0) and
cis-9-hexadecenoic acid (palmitoleic acid, C16:1 ω9c). The predominant menaquinone was
MK-9(H6), with minor amounts of MK-9(H4), MK-9(H8) and MK-9(H2). Galactose, glucose
and ribose were the main sugars found in the cell.
Identification of the zelkovamycin gene cluster
The genome-mining software analysis performed on the chromosome of Actinomadura
sp. 32–07 for the detection of genes involved in the production of secondary metabolites
uncovered the existence of at least 27 separate regions containing, among others, biosynthetic
gene clusters ascribed to terpene synthases, lanthipeptide synthases, type I and II polyketide
synthases (T1PKS and T2PKS) and non-ribosomal peptide synthetases (NRPS), and hybrids
thereof (Fig 3A). Some of these have high sequence similarity with gene clusters know to direct
the biosynthesis of secondary metabolites, such as ectoine (100% similarity), SapB (75%), nan-
changmycin (69%), DADH (51%), neoabyssomicin/ abyssomicin (50%), venezuelin (50%),
hopene (50%) and 2-methylisoborneol (50%).
The best match for a candidate zelkovamycin biosynthetic gene cluster was identified in a
~124-kbp region containing several contiguous ORFs predicted to code for complete NRPS,
T1PKS and T2PKS modules as well as several stand-alone domains. Specifically, three biosyn-
thetic genes in the region, hereby named zelA (ORF 2695), zelB (ORF 2694) and zelC (ORF
2693), were found to encode for eight NRPS modules whose arrangement, domain composi-
tion and substrate specificity agreed with the chemical structure and composition of zelkova-
mycin (Fig 3B and 3C). Some key similarities included a glycine-specific adenylation (A)
domain in conjunction with an N-methylation (NMT) domain for the incorporation of N-
methylglycine, an heterocyclisation (Cy) domain in conjunction with a cysteine-specific A
domain for the formation of a thiazoline ring, and a glycine-specific A domain for the incorpo-
ration of glycine. As with most NRPS systems, a putative initiation module lacking a condensa-
tion (C) domain and a termination module featuring a C-terminal thioesterase (TE) domain
were also present at opposing ends of the cluster.
On the other hand, some important domains and enzymes expected to take part in the bio-
synthesis of zelkovamycin were not automatically included in the software prediction, namely
the A domain in module 2, an oxidase (Ox) domain in module 5 (required for the oxidation of
the thiazoline ring into a thiazole heterocycle) and many of the stand-alone or post-synthetic
enzymes required for the modification or decoration of the zelkovamycin precursor. However,
additional BLAST and conserved domain prediction analyses on the translated DNA sequence
of modules 2 and 5 revealed the existence of selected regions with appreciable homology to
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Table 2. Main morphological, cultural and physiological traits that distinguish Actinomadura sp. 32–07 from A. macra NBRC 14102T.
Actinomadura sp. 32–07 A. macra NBRC 14102T
MORPHOLOGICAL FEATURES
Sporulation Yes, not evident Yes, scarce
Spore chains Flexuous Straight, flexuous, hooked or coiled
Spore number 10–20 4–15
Spore morphology Spherical, smooth Oval or elliptical, smooth




Aerial mycelium White to grey Grey to greyish
Substrate mycelium Dark brown Black
Soluble pigments None Brown
ISP 3
Growth Moderate Moderate
Aerial mycelium Pink to white Cream to faint pink
Substrate mycelium Pink Cream to faint pink
Soluble pigments None None
ISP 4
Growth Poor Very scant
Aerial mycelium Yellow to white Colourless or pale greyish
Substrate mycelium White Colourless
Soluble pigments None None
ISP 5
Growth Poor Poor
Aerial mycelium Dark green to dark brown Cream
Substrate mycelium Yellow-brown to green Cream
Soluble pigments None None
Nutrient agar
Growth Good Poor to moderate
Aerial mycelium White to pinkish Cream
Substrate mycelium Orange to pink Cream
Soluble pigments None None
Nutrient agar + gelatine
Growth Very good Moderate
Aerial mycelium Light pink and white, grey dots Avellaneous
Substrate mycelium Dark pink Avellaneous
Soluble pigments Faint yellow None
Nutrient agar + starch
Growth Very good Moderate
Aerial mycelium Light pink and white, grey dots Avellaneous
Substrate mycelium Light red Avellaneous
Soluble pigments Faint yellow None
Nutrient agar + tyrosine
Growth Very good Poor
Aerial mycelium Light pink, grey dots Cream to pale yellowish
Substrate mycelium Light red, black dots Cream to pale yellowish
Soluble pigments Faint brown None
(Continued)
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Table 2. (Continued)
Actinomadura sp. 32–07 A. macra NBRC 14102T
Milk agar
Growth Poor None or few colonies
Aerial mycelium Dark purple to light red Pale pinkish orange
Substrate mycelium Dark purple to light red Pale pinkish orange




Aerial mycelium Grey Pinkish orange
Substrate mycelium Dark green and pink Pinkish orange
Soluble pigments None Pale yellow
Jensen isolation agar
Growth Poor Poor to moderate
Aerial mycelium Light brown with pink and dark purple Colourless to cream
Substrate mycelium Light brown with pink and dark purple Colourless to cream
Soluble pigments Faint yellow or light green None
Czapek’s agar
Growth Poor Poor
Aerial mycelium Brown to light brown Pale cream
Substrate mycelium Brown to light brown Colourless
Soluble pigments Light brown None
Emerson’s agar
Growth Poor Moderate to good
Aerial mycelium Light red with dark purple Greyish, black
Substrate mycelium Pink with light brown Greyish, black
Soluble pigments Yellow None
Water agar
Growth Scant Scant
Aerial mycelium Colourless Colourless
Substrate mycelium Colourless Colourless
Soluble pigments None None
PHYSIOLOGICAL FEATURES
Utilisation of sole carbon sources (1.0%, w/v):
L-Arabinose ± -
D-Glucose ++ +
Utilisation of sole nitrogen sources (0.1%, w/v):
L-Leucine - + ‡
L-Phenylalanine - + ‡
L-Valine - + ‡
Temperature tolerance:
10 ˚C - + ‡
22 ˚C - +
45 ˚C - - / + ‡
pH tolerance:
pH 9.0 - + ‡
Degradation of:
Casein + - / + ‡
(Continued)
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Table 2. (Continued)
Actinomadura sp. 32–07 A. macra NBRC 14102T
Elastin - + ‡
Hypoxanthine + - ‡
Starch + -
Tributyrin - + ‡
Tween 40 ± + ‡
Tyrosine + + / − ‡
Resistance to inhibitory compounds:
Ampicillin - + ‡
Neomycin - - (above 3 μg/mL) ‡
Unless indicated otherwise, data for the reference strain of A. macra was taken from the original description of the species [57]. Growth on single carbon sources was
rated as follows: “++” equal or greater than the positive control, “+” better than negative control but less than the positive control, “±” only slightly better than the
negative control, “-”similar or less than the negative control.
‡: Data from Trujillo and Goodfellow [59].
https://doi.org/10.1371/journal.pone.0260413.t002
Table 3. Summary of the main chemotaxonomic markers of Actinomadura sp. 32–07.
Chemotaxonomic markers Type and quantity
Isomer of DAP DL-DAP
Mycolic acids Absent


















Whole-cell sugars Galactose, glucose, ribose
DL-2,6-diaminopimelic acid (DL-DAP), but no mycolic acids, are present in the cell wall. Phosphatidylinositol (PI),
diphosphatidylglycerol (DPG) and phosphoglycolipid (PGL) are the main phospholipids, with palmitic acid as the
predominant fatty acid. The menaquinone system is mainly composed of MK-9(H6). Galactose, glucose and ribose
are the main sugars. Fatty acids that contributed to less than 1% of the total are omitted.
https://doi.org/10.1371/journal.pone.0260413.t003
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Fig 3. Selected results of the antiSMASH analysis on the genome of Actinomadura sp. 32–07. (A) A total of 27 regions were identified that
contained one or more predicted biosynthetic clusters. (B) Of all the results, only region 11 (124,153 bp) contained a gene cluster coding for
NRPS modules whose arrangement and domain composition agreed with the chemical structure of zelkovamycin (zelA–C). The core
biosynthetic clusters in the region are highlighted in red and ORFs are numbered according to their position in the genome. Where available,
the modules and domains coded by the ORFs of interest and their predicted substrate specificity are shown. (C) Schematic of the
organization of the putative zelkovamycin synthetase according to the structure of zelkovamycin. The similarities between the expected
residue specificity of some A domains and the respective software prediction are illustrated, along with the domains missing from the
software prediction.
https://doi.org/10.1371/journal.pone.0260413.g003
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amino acid adenylation domains (TIGR01733) and mcbC-like oxidoreductase domains
(cd02142), respectively, leading to the hypothesis that the corresponding enzymatic activities
may still be provided in some form by each module.
A similar analysis on two genes immediately downstream of zelC (ORFs 2692 and 2691, Fig
3B) revealed that the translated nucleotide sequence of ORF 2691 (zelE) has appreciable
homology to the tryptophan 2,3-dioxygenase superfamily (TIGR03036), members of which
have been previously found and characterised in Amycolatopsis and Streptomyces species
(GenBank SEF24281.1 and PKV74255.1). The product of ORF 2692 (zelD) instead showed
sequence homology to enzymes in the superfamily of S-adenosylmethionine-dependent
methyltransferases (SAM-MT), some of which specifically target oxygen atoms (O-MT) and
have been previously characterised in Streptomyces and Nonomuraea species (GenBank
SFT14077.1, WP_016573776.1 and AIW58898.1). It is therefore postulated that ZelD and ZelE
may be involved in the formation of the characteristic 4-methoxytryptophan residue of zelko-
vamycin, which is likely to originate from a tryptophan residue incorporated by domain A6.
Further analysis supported the existence of other undetected NRPS-associated enzymes in
the coding sequences surrounding zelA–C, although their precise role in the biosynthesis and
maturation of zelkovamycin could not be postulated with enough confidence. However, it is
worth noting that ORFs 2697 (zelF) and 2687 (zelG), two biosynthetic genes located in close
proximity of zelA–E (Fig 3B), both contain an A domain with predicted threonine selectivity
and are flanked by additional biosynthetic genes coding for different types of enzymes. These
independent modules could mediate the incorporation of Thr in the zelkovamycin precursor,
which could then be further modified in trans or post-synthetically to yield the 2-amino-
2-butenoic acid (i.e. dehydrobutyrine), the 2-aminobutyric acid or the 2-methyl dehydro thre-
onine residues found in mature zelkovamycin [15].
Overall, this analysis supports the case for the biosynthetic gene cluster of zelkovamycin in
Actinomadura sp. 32–07, in which the cluster is comprised of at least five adjacent genes, three
of which are likely to be sufficient for the production of a complete zelkovamycin precursor.
Thus, the zelkovamycin synthetase is postulated to consist of three core multimodular enzymes
accounting for eight NRPS modules (Fig 3C). ZelA (2,719 aa) features the first three modules
of the biosynthetic chain, with module 1 as the initiation module and module 3 being responsi-
ble for the incorporation of glycine and its methylation to N-methylglycine (i.e. sarcosine).
The following three elongation modules are found in ZelB (3,567 aa), with the central one pro-
viding the cysteine selectivity and most (or all) the catalytic activities required for the forma-
tion of a thiazole ring with the upstream residue. ZelC (2,341 aa) encloses modules 7 and 8, the
latter being responsible for the incorporation of glycine and acting as the termination module
for the cyclisation and release of the completed peptide chain. Two additional enzymes, ZelE
(a tryptophan 2,3-dioxygenase) and ZelD (an O-methyltransferase) are predicted to modify
the Trp6 to afford a 4-methoxytryptophan residue.
Very recently, the biosynthetic gene cluster of argyrins (a class of cyclic non-ribosomal pep-
tides produced by Archangium and Cystobacter species) has been identified and characterised
[60]. Due to the striking structural similarities between zelkovamycin and argyrins (Fig 4A),
the NRPS system and, therefore, the gene composition and organisation of the biosynthetic
cluster of argyrins can be expected to reflect those of zelkovamycin. Indeed, the comparison
between the published argyrin synthetase and its characterised gene cluster further supported
the present findings (Fig 4B and 4C). Additionally, the presence of an Ox domain fused to
module 5 of argyrin synthetase corroborated the initial hypothesis that an oxidase activity may
be provided by the corresponding module of the zelkovamycin synthetase. Furthermore, arg4
and arg5 (homologs of zelD and zelE, respectively) were identified to encode the O-methyl-
transferase and the tryptophan 2,3-dioxygenase responsible for the oxidation and methylation
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Fig 4. (A) Comparison between the linear structures of zelkovamycin and argyrins, (B) the NRPS systems behind their
production and (C) the core biosynthetic genes coding for them. Genes, modules and amino acid residues of each compound
are color-coded. The structure of the argyrin cluster and argyrin synthetase are adapted from Pogorevc et al. [60].
https://doi.org/10.1371/journal.pone.0260413.g004
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of the Trp7 to yield a 4-methoxytryptophan residue in argyrin, thus supporting the case for a
similar function in the biosynthesis of zelkovamycin.
Following the completion of this work and during the preparation of this manuscript, the
isolation of zelkovamycin and its four analogues zelkovamycin B-E from Kitasatospora sp.
CPCC204717 [62] was reported. In this study, a putative biosynthetic cluster for the five pep-
tides was proposed, which largely agrees with the model described in the present work. In par-
ticular, the orf5, orf6 and orf7 reported by Hao et al. supports the provisional role of zelA, zelB,
and zelC as the main actors in the assembly of a zelkovamycin precursor. In further accordance
with our observations, the presence of an Ox domain in module 5 has also been predicted in
the zelkovamycin cluster (annotated Ox5) found in Kitasatospora, as well as the role of ZelF or
ZelG as potential trans-acting standalone modules or domains providing the adenylating func-
tionality missing from module 2.
Lastly, each of the five ZelA-ZelE proteins was queried with BLASTP against the non-
redundant protein database at the NCBI (default parameters), collating the 100 top hits for
each protein (S2 File). These 500 hits originated from 309 different database organisms, which
TaxID numbers were extracted to build a Venn diagram (S2 Fig). Under these conditions,
presently Cystobacter sp. SBCb004 (GenBank MK047651.1) is the only organism that can be
found to encode significant homologues to all five proteins (S3 Fig) in the 32.9-kb argyrin bio-
synthetic gene cluster [60].
Zelkovamycin production
Following 10 days of growth in fermentation broth, the spent medium and the mycelial bio-
mass of Actinomadura sp. 32–07 were harvested, separated and subjected to solid-phase
extraction using Diaion HP-20 polystyrene resin. In parallel, the starting seed medium used to
inoculate the fermentative culture was also extracted with the same procedure. The resin from
each sample was eluted with increasing concentrations of methanol in water, and all the eluates
were analysed by LC-MS. In all cases, a monodisperse molecular ion peak (MH+ 780.314)
could be detected and eluting at 6.14 min. These results were in line with the values obtained
using a commercial sample of zelkovamycin (Fig 5A) and those found in the literature [12,
61], thus confirming that zelkovamycin was present in both the spent culture media and in the
mycelium. However, the comparison between the area of the zelkovamycin peaks for each
sample revealed that the fermentation medium contained approximately double the amount
of zelkovamycin (8.3 μg/mL) than the seed medium (3.4 μg/mL), while only negligible quanti-
ties were present in the mycelium (Fig 5B). This result suggests that zelkovamycin is constitu-
tively produced during the early stages of growth and actively released into the fermentation
medium.
When tested against Staphylococcus aureus SH1000 by the disk diffusion method, the zelko-
vamycin extracts from the seed culture, the fermentation broth and the harvested mycelium all
showed antimicrobial activity to variable extents, compatibly with the different concentration
of antibiotic detected in each fraction (Fig 5C). Overall, the inhibitory effect was found to be in
line with previous observations [12], indicating the zelkovamycin produced by Actinomadura
sp. 32–07 retains its biological activity.
Conclusions
Actinomadura graeca (grae.ca. N.L. fem. adj. graeca of or belonging to Greece, where the type
strain was isolated) is an aerobic, Gram-positive, non-acid-alcohol-fast, non-motile actinomy-
cete that forms extensively branched substrate mycelium and spore-bearing aerial hyphae.
Long, flexuous series of subtle oval swellings carry an average of 10–20 small, spherical, smooth
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Fig 5. Detection, purification and antibiotic activity of zelkovamycin from Actinomadura sp. 32–07. (A) Extracted ion chromatograms of
commercial zelkovamycin (top) and a representative example of an extracted sample (bottom). Zelkovamycin can be detected as a monodisperse peak
eluted at 6.14 min. (B) Zelkovamycin extraction steps from the inoculum medium, the fermented medium and the harvested mycelium. The compound
is present in both culture media and can be successfully extracted upon resin elution with 100% methanol. (C) Antibiotic sensitivity testing on S. aureus
SH1000 using the most concentrated zelkovamycin extracts (E3) from each fraction. The lower concentration of antibiotic in the extracts obtained from
the seed culture and the mycelium is reflected by their significantly lower, albeit detectable, inhibitory activity. FT: flow-through; W: water wash; E1–3:
20%, 50% and 100% MeOH elution, respectively; Z: zelkovamycin standard (1 mg/mL); S: seed culture extract; F: fermented broth extract; M: mycelium
extract; C: 100% MeOH control.
https://doi.org/10.1371/journal.pone.0260413.g005
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spores. Single round terminal swellings are also present sometimes. Growth on rich agar
media is generally good and often appears brown, light brown or yellow, shifting to white or
grey towards maturation. Melanoid pigments are not produced on ISP medium 6 and 7 or in
any other tested media. Soluble colours, such as light yellow, orange and dark yellow, can be
observed on ISP 1, GYEA and Tsukamura’s medium, respectively. Optimal growth conditions
fall between 28–37 ˚C, pH 6.0–8.0 and 0–3% (w/v) of NaCl. D-glucose and sucrose are utilised
as sole carbon sources on ISP medium 9, but not myo-inositol, D-mannitol, L-rhamnose, raffi-
nose or cellulose. The microorganism degrades aesculin, arbutin, hypoxanthine, gelatine,
starch, L-tyrosine, casein, Tween 20, Tween 40, Tween 60 and Tween 80 but not elastin, xan-
thine, xylan or tributyrin.
Actinomadura graeca is most sensitive to bacitracin, imipenem, linezolid, ticarcillin and
clindamycin. DL-DAP is present in the cell wall, but it lacks mycolic acids. The predominant
phospholipids are PI, DPG and PGL, rich in C16:0, C18:1 ω9c, 10-methyl-C18:0 and C16:1 ω9c
fatty acids. The menaquinone system mainly consists of MK-9(H6), MK-9(H4) and MK-9(H8).
The results for most of the morphologic, physiological and chemotaxonomic tests per-
formed on the isolate were in alignment with those expected from members of the genus Acti-
nomadura. However, features like the lack of clearly visible spores, the presence of DL-DAP
(rather than meso-DAP) and the absence of madurose (the diagnostic sugar, often found in
trace amounts) stood out as the most salient differences.
The type strain 32-07T (designated DSM 111581 and NCTC 14609 in the relevant culture
collection) has been isolated from a soil sample in Santorini, Greece. Based on chemotaxo-
nomic data and genomic, 16S rRNA and rpoB/rpoC gene sequence homologies, it is suggested
that this strain represents a member of the genus Actinomadura. Nevertheless, its peculiar
morphological, cultural and biochemical characteristics, as well as phylogenetic data, support
the hypothesis that strain 32-07T represents a novel species, for which the name Actinomadura
graeca sp. nov. is proposed. The chromosome is made up of 8,944,773 bp with a G+C content
of 72.36 mol%.
Significantly, the new species has been confirmed as a producer of the macrocyclic peptide
antibiotic zelkovamycin. The antibiotic could be extracted from a liquid culture of the strain
by incubation with a polystyrene resin and it is maximally eluted with 100% methanol. When
tested against S. aureus SH1000, the extracted peptide was found to retain the antibacterial
activity highlighted in previous studies [12, 61]. During the preparation of this manuscript,
Hao et al. reported that zelkovamycin displayed potent antimicrobial activity against both S.
aureus ATCC 29213 and S. epidermidis ATCC 12228 [62].
Most of the biosynthetic genes coding for the NRPS machinery behind the production of
zelkovamycin have been uncovered in this study. The provisional model consists of three core
biosynthetic genes (zelA–C) coding for a total of eight NRPS modules, the majority of which
contain the expected C, A and T domains required to direct the biosynthesis of a complete
zelkovamycin precursor. Two additional genes (zelD–E) are also proposed to be part of the
biosynthetic gene cluster, as they encode for a stand-alone tryptophan 2,3-dioxygenase and an
O-methyltransferase, and are likely involved in the production of a key residue, 4-methoxytrp-
tophan in zelkovamycin. The comparison of the putative zel cluster with the recently published
cluster for the structurally related argyrins [60] revealed several similarities that corroborate
these conclusions. Nevertheless, further biochemical data is needed to validate the present
findings and unambiguously identify the remaining genes involved in the biosynthesis of
zelkovamycin.
In conclusion, the data hereby provided represents the first instance of a species outside the
genus Streptomyces being reported as a source of zelkovamycin and paves the way towards the
exploitation of the biosynthetic potential of this microorganism.
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Supporting information
S1 File. Initial isolation of Actinomadura graeca 32–07.
(PDF)
S2 File. Each of the five ZelA-ZelE proteins was queried with BLASTP against the non-
redundant protein database at the NCBI, and the resulting 100 top hits for each protein
are listed.
(XLSX)
S1 Fig. Maximum likelihood tree generated from the RNA polymerase subunit genes rpoB/
rpoC showing the relationship between Actinomadura sp. 32–07 and the type strains of
species in the genus Actinomadura.
(TIF)
S2 Fig. Venn diagram representing the conservation of the ZelA-ZelE proteins among
diverse GenBank taxa. The five proteins were individually queried with BLASTP against the
NCBI non-redundant protein database (default parameters) and unique TaxIDs of the first
100 hits for each protein (309 TaxIDs in total) were extracted to build the diagram. Under
these conditions, only two organisms were found to encode significant homologues to these
five proteins: Actinomadura 32–7 (source of the sequences) and Cystobacter sp. SBCb004.
(TIF)
S3 Fig. Alignment and homologies of the zelABCDE and arg12345 clusters of Actinoma-
dura 32–7 and Cystobacter sp. SBCb004, respectively, at the protein levels. Overall, the
ZelABCDE proteins are in average 51% identical and 65% similar to the Arg2345 proteins over
98% of their cumulated length, with a significant homologue of Arg1 (radical SAM-dependent
methyltransferase) not being found to be encoded in the genome of Actinomadura 32–7. i: per-
cent identity, s: percent similarity.
(TIF)
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